Hyperphosphataemia is associated with increased adverse outcomes, including mortality. Re‐examining this association using up‐to‐date data reflecting current and real‐world practices, across different global regions and in both haemodialysis and peritoneal… Click to show full abstract
Hyperphosphataemia is associated with increased adverse outcomes, including mortality. Re‐examining this association using up‐to‐date data reflecting current and real‐world practices, across different global regions and in both haemodialysis and peritoneal dialysis patients, is important.
               
Click one of the above tabs to view related content.